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ABSTRACT
Background Since at least the late 1990s, HIV has been
viewed as a major threat to efforts by countries to
reduce under-5 mortality. Previous work has documented
increased under-5 mortality due to HIV from 1990 to
1999 in Africa. The current analysis presents estimates
and trends in under-5 mortality due to HIV in low- and
middle-income countries by region up to 2009.
Methods The analyses are based on the national models
of HIV and AIDS produced by country teams in
coordination with UNAIDS and its partners for the years
1990e2009. These models produce a time series of
estimates of HIV-related mortality as well as overall
mortality in children aged <5 years.
Results and conclusion These analyses indicate that,
in 2009, HIV accounted for roughly 2.1% (1.2e3.0%) of
under-5 deaths in low- and middle-income countries and
3.6% (2.0e5.0%) in sub-Saharan Africa. The percentage
of under-5 deaths due to HIV has been falling in the last
decadedfor example, from 2.6% (1.6e3.5%) in 2000 to
2.1% (1.2e3.0%) in 2009 in low- and middle-income
countries and from 5.4% (3.3e7.3%) in 2000 to 3.6%
(2.0e5.0%) in 2009 in sub-Saharan Africa. This fall in the
percentage of under-5 deaths due to HIV has been driven
by a combination of factors including scale-up of
prevention of mother-to-child transmission programmes
and treatment for pregnant women and children as well
as a decrease in the prevalence of HIV among pregnant
women.
INTRODUCTION
In 2001 the global community came together in the
United Nations special session on HIV/AIDS and
agreed to a set of global targets in response to
a rapidly escalating global public health crisis.
1
While there were speciﬁc targets set for AIDS, there
was also an acknowledgement of the impact that
HIV and AIDS could have on the goals for child
survival. Speciﬁcally, it was argued that increases in
HIV-related mortality could make it difﬁcult for
many countries with a high prevalence of HIV to
reach their goals for under-5 mortality.
Previous work has investigated the relative
importance of HIV as a cause of death among chil-
drenatcountryandregionallevels.
2e4Amorerecent
analysis of the causes of child deaths found that, in
2008,deathsduetoHIVwerethecauseof4%ofchild
deaths in Africa.
5 Another analysis of the trend in
under-5 mortality found that overall mortality
in children younger than 5 years has decreased from
11.9 million deaths in 1990 to 7.7 million deaths in
2010.
6 Increasing coverage of HIV interventions has
animpactonthenumberofchildrendyingfromHIV.
These interventions include scale-up of programmes
to prevent mother-to-child transmission of HIV
(PMTCT), antiretroviral therapy (ART) for children
with HIVand ART for adults. All of these interven-
tionshavebeenscaledupinthelastfewyearsandall
should have a signiﬁcant impact on HIV-related
deaths in children under the age of 5 years.
78
In addition, there is increasing evidence that the
prevalence of HIVin adults and in pregnant women
has peaked and fallen in some of the countries with
a higher HIV prevalence. These include countries
such as Zimbabwe,
9 Ethiopia,
10 Zambia
11 and
Kenya.
12 These reductions in prevalence will result
in fewer children being exposed to HIV via mother-
to-child transmission and could have a signiﬁcant
impact on overall under-5 deaths due to HIV.
In this paper we use the most recent estimates of
HIV to look at the overall trend in mortality due to
HIVinchildrenfrom1990to2009.Firstweestimate
the number of under-5 deaths due to HIV by year
from 1990 through 2009; second, we estimate the
proportion of under-5 mortality due to HIV; and,
third, we look at the relative impact of PMTCT,
ARTand falling prevalence on under-5 mortality due
to HIV. For all of these analyses we present esti-
mates for low- and middle-income countries with
a primary focus on sub-Saharan Africa.
METHODS
The national and global HIV estimation process
began with country-speciﬁc estimates of HIV
prevalence collected through biennial regional
workshops and analysed using the Estimates and
Projection Package (EPP), Workbook and Spectrum
software packages whose methodology is described
elsewhere.
13e15 Brieﬂy, for countries with a gener-
alised epidemic, EPP ﬁts a simple epidemiological
model developed by the UNAIDS Reference Group
on Estimates, Modelling and Projections to
observed HIV surveillance data using a maximum
likelihood method. For countries with a concen-
trated epidemic, HIV prevalence is estimated by
combining the HIV prevalence in speciﬁc high- and
low-risk population groups with an estimate of the
size of these groups. For countries with enough
trend data, EPP is used to ﬁt a curve for the various
high- and low-risk populations. For countries with
limited data, the Workbook method is repeated for
several years and then a prevalence trend is derived
in EPP. For countries where a national household
survey has collected HIV prevalence data, this
information is used as well as the sentinel surveil-
lance data to inform the estimates of adult preva-
lence and the male:female ratios.
Time trends of the incidence of HIV in adults
(age 15e49 years) are then transferred to Spectrum
and the data are entered for coverage of all PMTCT
interventions (notably antiretroviral (ARV) agents
1UNAIDS, Geneva, Switzerland
2The Futures Institute,
Glastonbury, Connecticut, USA
3UNICEF, New York, USA
Correspondence to
Karen Stanecki, UNAIDS, 20
Avenue Appia, 1211 Geneva,
27, Switzerland;
staneckik@unaids.org
Accepted 7 October 2010
This paper is freely available
online under the BMJ Journals
unlocked scheme, see http://sti.
bmj.com/site/about/unlocked.
xhtml
ii56 Sex Transm Infect 2010;86(Suppl 2):ii56eii61. doi:10.1136/sti.2010.046201
Supplementfor prophylaxis or treatment, infant feeding modes and dura-
tion), ART and child treatment for each year. Estimated HIV
outcomes (eg, HIV incidence, HIV prevalence and mortality due
to HIV by age and sex) are then produced using the AIDS
Impact Model module. New infections in children are calculated
as a proportion of total births. That proportion is the product of
HIV prevalence among pregnant women in each age group and
the mother-to-child transmission rate and is adjusted for the
fertility of HIV-infected women. The transmission rate is
determined by the treatment regimen (single, dual, triple or no
therapy), type of feeding (mixed breast feeding, exclusive breast
feeding, no breast feeding) and the length of breast feeding.
14
Non-HIV-related mortality in children is determined by the
estimates of life expectancy in the absence of AIDS from the UN
Population Division 2008 revision and the appropriate model life
table. HIV-related deaths in children are calculated based on the
number of HIV-positive children, their rate of progression to
death with and without ART and the effects of cotrimoxazole
and ARTon enhancing survival.
The Spectrum software tracks children separately for those
infected during pregnancy and delivery (perinatal transmission)
and those infected after birth through breast feeding. In both
cases, survival by age follows a double Weibull distribution.
16 17
For children infected at birth, the pattern shows 51% survival by
age 1, 39% by age 2 and 35% by age 5. For children infected
through breast feeding, the pattern shows 77% survival 1 year
after infection, 65% after 2 years and 59% after 5 years.
The assumed perinatal transmission rates for different ARV
regimens are as follows:
< No ARV: 20%.
< Single-dose nevirapine: 11%.
< Combination therapy using dual prophylaxis: 4%.
< Combination therapy using triple prophylaxis ARV: 2%
(there is also a separate input for mothers on ART for their
own health with the same transmission rate).
HIV-exposed infants born HIV-negative (uninfected) have
a monthly probability of HIV infection based on the infant
feeding method and duration as well as use of ARV drugs during
breast feeding. The assumed monthly transmission rates during
breast feeding are estimated to be:
< Replacement feeding: 0%.
< Mixed breast feeding during months 1e6: 1.5%.
< Exclusive breast feeding during months 1e6: 0.75%.
< Mixed breast feeding 6e36 months: 0.75%.
< Breast feeding in the presence of maternal ART or effective
prophylaxis: 0.3%.
Spectrum projections from 117 low- and middle-income
countries from sub-Saharan Africa, Latin America and the
Caribbean, Eastern Europe and Asia were used in this study and
all results throughout refer to these countries. HIV-related
deaths in children aged <5 years as well as deaths due to all
causes including HIV were extracted from Spectrum for each
country and summed by region and globally. The proportion of
under-5 mortality attributable to HIV was then calculated.
Plausibility bounds for deaths due to HIV in children aged
<5 years were calculated based on the uncertainty bounds for
deaths due to HIV in children aged 0e14 years calculated
through a Monte Carlo procedure that varies all key assump-
tions including adult HIV prevalence, the rate of mother-to-child
transmission, the rate of progression and the effectiveness of
treatment. Deﬁnitions of regions can be found on the UNAIDS
website under AIDS Info.
18
We also considered the relative impact of three interventions
on mortality: declining HIV incidence among pregnant women,
PMTCT programmes and child ART programmes. Using two
country ﬁles with a recently declining prevalence of HIVamong
pregnant women (Botswana and Zimbabwe), several scenarios
were developed to measure this impact.
19 20 We used the basic
EPP and Spectrum ﬁles to estimate HIV in each country and
then modiﬁed the inputs. The following scenarios were devel-
oped varying only one parameter:
1. Changing declining incidence to stable incidence as of 2000.
2. Removing all PMTCT programme data.
3. Removing all child ARTcoverage.
4. Removing all cotrimoxazole coverage for children exposed to
HIV.
RESULTS
The number of deaths attributable to HIV in children aged
<5 years increased from 69000 (38000e110000) in 1990 to
260000 (160000e340000) in 2002 (the peak year) before
declining to 170000 (100000e250000) in 2009 (ﬁgure 1). The
proportion of deaths due to HIV among children aged <5 years
of all deaths in children <5 years reached a peak in 2004 of 2.9%
(1.9e3.9%) and began to decline thereafter to 2.2% (1.3e3.1%)
in 2009.
In countries outside sub-Saharan Africa the proportion of
deaths among children aged <5 years attributable to HIV peaked
at >0.4% in 2002 and has started to fall slightly since 2007
(ﬁgure 2).
In sub-Saharan Africa the proportion of deaths in children
<5 years of age due to HIV reached a peak at 5.4% (3.4e7.4%) in
Figure 1 Number of deaths due to HIV
in children aged <5 years in
sub-Saharan Africa, Latin America and
the Caribbean, Eastern Europe and Asia,
1990e2009.
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Supplement2002 and began to decline thereafter to 3.6% (2.0e5.0%) in 2009
(ﬁgure 3). This pattern varies by region in sub-Saharan Africa, as
shown in ﬁgure 4.
The highest proportion of deaths among children due to HIV
is seen in Southern Africa. In 1990 the proportion of deaths due
to HIV among children aged <5 years was similar in Southern
and Eastern Africa. However, that pattern changed, reﬂecting
the rapidly increasing HIV epidemic in Southern Africa and, in
most countries of that region, lower levels of under-5 mortality
due to non-HIV-related causes.
6 In 2003 an estimated 15.5%
(11.4e19.1%) of all deaths among children aged <5 years were
due to HIV; by 2009 there was a decline of >55% to 9.9%
(6.6e12.2%) in Southern Africa. In Central Africa the proportion
of HIV-related deaths peaked in 2003 at 2.5% (1.3e3.6%) and
declined to 2.0% (1.0e3.0%) in 2009. In Eastern Africa the
proportion of HIV-related deaths among under-5 mortality
peaked in 1999 at 6.5% (3.5e9.3%) and decreased to 3.6%
(1.5e6.2%) in 2009, a decline of nearly 45%. In Western Africa
the proportion of under-5 deaths due to HIV declined from 2.9%
(1.5e4.2%) in 2000 to 2.3% (1.1e3.4%) in 2009.
In 2009 the number of HIV-related deaths in children aged
<5 years in sub-Saharan Africa was highest in Nigeria (>30000)
and South Africa (>20000) (ﬁgure 5). Overall, Eastern Africa
showed relatively high numbers of HIV-related deaths in chil-
dren <5 years of age. In countries outside sub-Saharan Africa,
the country with the highest estimated number of HIV-related
deaths was India (7700 (3200e14000)). All other countries had
fewer than 1000 HIV-related deaths in children aged <5 years.
The proportion of under-5 deaths attributable to HIV was
highest in countries in Southern Africa, including Lesotho,
Namibia, South Africa, Swaziland and Zimbabwe (all >20%) in
2009 (ﬁgure 6). The proportion of under-5 deaths attributable
to HIV in Botswana peaked at 48.2% (27.5e63.0%) in 2001
and declined to 16.0% (6.2e23.1%) in 2009. Similarly, in
Swaziland the proportion of under-5 deaths attributable to HIV
peaked at 39.0% (24.3e50.1%) in 2005 but declined to 22.3%
(11.0e34.0%) in 2009. The proportion in South Africa declined
from a peak of 38.0% (22.0e49.7%) in 2004 to 26.0%
(15.0e34.5%) in 2009.
The results of the various scenarios to analyse the relative
impact of declining incidence, PMTCT programmes and child
treatment show that PMTCT had the largest relative impact. In
Botswana the estimated HIV-related under-5 mortality was
380% higher when analysed without the impact of PMTCT
while in Zimbabwe there was an estimated 17% increase in HIV-
related mortality. When no child ART programmes were
implemented, there was a 5% change in HIV-related mortality in
both Botswana and Zimbabwe, while stable HIV incidence
among pregnant women resulted in increases of 14% and 19% in
HIV-related mortality in the two countries. Cotrimoxazole
resulted in a 26% increase in HIV-related mortality in Botswana
and a 10% increase in Zimbabwe (table 1).
Figure 2 Proportion of under-5
mortality attributable to HIV in low- and
middle-income countries in Latin
America and the Caribbean, Eastern
Europe and Asia, 1990e2009.
Figure 3 Proportion of under-5
mortality attributable to HIV in
sub-Saharan Africa, 1990e2009.
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The Millennium Development Goal 4 (MDG4) target is to
reduce the under-5 mortality rate by two-thirds between 1990
and 2015. A recent analysis shows that, in all regions of the
world including all regions in sub-Saharan Africa, there is
evidence of accelerating declines from 2000 to 2010 compared
with 1990 to 2000. Within sub-Saharan Africa the rates of
decline have increased by more than 1% in several countries,
including some of those most severely affected by HIV such as
Botswana, Kenya, Lesotho and Swaziland.
6
We have explored the contribution of HIV to trends in under-5
mortality by producing estimates of the proportion of under-5
mortality due to HIV in developing countries, with a speciﬁc
focus on sub-Saharan Africa, for the period 1990e2009. Globally,
in low- and middle-income countries the proportion of deaths
due to HIV among children aged <5 years increased up to 2.8%
(1.8e3.8%) in 2004 and then declined to 2.1% (1.2e3.0%) in
2009. In sub-Saharan Africa the proportion of deaths due to HIV
among children aged <5 years increased to 5.4% (3.3e7.3%) in
2001e2 and declined to 3.6% (2.0e5.0%) in 2009.
Although Nigeria has more under-5 deaths due to HIV than
most countries in Southern Africa, the overall proportion of
under-5 deaths due to HIV is lower than in those countries. The
countries in Southern Africa have lower overall mortality among
children aged <5 years from other causes.
We also calculated the proportion of HIV-related deaths in
a comparable set of 41 countries in sub-Saharan Africa to under-
5 mortality estimated by the Institute for Health Metrics and
Evaluation (IHME).
6 The overall pattern remains the same, with
the peak occurring in 2002 for these countries. The estimated
proportions using the IHME denominators are similar with 6.3
in 2002 compared with 5.4 using the Spectrum estimates of total
under-5 deaths. The estimated proportion of HIV-related deaths
in 2009 using the IHME estimates of under-5 mortality is 4.3
compared with the estimated proportion of 3.6 using the
Spectrum estimates of under-5 mortality.
Figure 4 Proportion of under-5
mortality attributable to HIV in African
subregions, 1990e2009.
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Figure 5 Number of under-5 deaths
attributable to HIV in sub-Saharan
Africa, 2009.
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SupplementTwo previous assessments of the contribution of HIV to under-
5 mortality showed that HIV was responsible for an increasing
proportion of child deaths throughout 2002.
21e23 The current
assessment through 2009 shows a decreasing proportion in the
most recent years. The decline in deaths due to HIV can be
attributed to a number of factors. During this time period the
prevalence of HIVin adults (15e49 years of age) began to decline
in several sub-Saharan African countries including Uganda,
Kenya, Burkina Faso, Cote d’Ivoire and Zimbabwe. These
declines in the adult prevalence of HIV would result in fewer
children being born HIV-positive. Since many HIV-positive
children die within the ﬁrst year of life, rapid changes in preva-
lence among adult women will quickly translate into changes in
under-5 mortality.
24 Also, during this period, progress was made
to increase the coverage of maternal ARV agents to prevent
mother-to-child transmissiondfor example, from 10% to 53%
between 2004 and 2009 in low- and middle-income coun-
triesdagain resulting in fewer HIV-infected children being born.
7
24 In addition, an increasing number of pregnant women are
receiving ART for their own health, reducing HIV transmission
to their children and lengthening their lives, thereby reducing
mortality among their children (both HIV-positive and HIV-
negative).
25 In South Africa, in a largely rural population with
a high antenatal HIV prevalence, deaths in infants aged <2 years
declined by49% between2001and2006.
26This wasattributed to
the availability ofPMTCTandARTinpublic health programmes.
Finally, during the same period the number of children aged
<14 years in low- and middle-income countries on ARTincreased
from 75000 in 2005 to 356400 in 2009 (28% (21e43%) coverage
of children in need of ART), resulting in fewer deaths.
7
The analysis of varying scenarios in two countries with
a declining incidence of HIV showed the relatively important
impact of PMTCT programmes on under-5 mortality when
PMTCTcoverage is high. All components, however, contributed
to the reduction in under-5 mortality. Although the impact of
child ART on child mortality is similar for Botswana and
Zimbabwe with different programme coverage, that coverage is
distributed over the entire range of 0e14 years of age while our
measure only reﬂects children aged <5 years. Additionally, many
children are not diagnosed in time and may die before being
determined to be eligible for ART. Finally, ART scale-up in chil-
dren has only occurred over the past few years.
HIV infection progresses more aggressively in infants infected
during birth and delivery than in adults. Early treatment within
the ﬁrst few months of life can dramatically improve the
survival rates of children with HIV. However, many children
do not receive treatment as soon as needed; indeed, many chil-
dren die before it is determined that they are infected with HIV.
New WHO guidelines recommend that all infants <1 year of age
with conﬁrmed HIV infection should start ART, irrespective of
the clinical or immunological stage. Also, while PMTCT
programmes have been scaled up dramatically in the last
10 years, current levels of coverage are still low. In 2009 over half
of the 1.4 million pregnant women living with HIV are
estimated to have received ARV drugs to prevent transmission of
HIV to their infants. An estimated 53% (40e57%) of pregnant
women living with HIV received ARV drugs to reduce the risk
of transmitting HIV to their infants, up from 45% (37e57%)
in 2008 and 15% (12e18%) in 2005.
7 An increased commitment
to greater coverage and use of more effective ARV regimens will
Figure 6 Proportion of under-5 deaths
attributable to HIV in sub-Saharan
Africa, 2009.
u
o
S
t
a
c
i r
f
A
h
e
w
b
a
b
m
i
Z
d
n
a
l i
z
a
w
S
t
o
s
e
L
ho
b
i
m
a
N
ia
s
t
o
B
w
a
n
a
Ma
w
a
l
i a
i
b
m
a
Z
n
o
b
a
G
Mo
q
i
b
m
a
z
ue
a
y
n
e
K
a
d
n
a
g
U
n
o
o
r
e
m
a
C
u
q
E
a
a
e
n
i
u
G
l
a
i r
o
t
a
i
n
a
z
n
a
T
R
U
o
g
o
T
o
g
n
o
C
t
o
C
e
e
r i
o
v
I
d
r
t
n
e
C
a
c
i l
b
u
p
e
R
n
a
c
i r
f
A
l
a
i r
e
g
i
N r
u
B
u
i
d
n
Ma
s
u
i t i r
u
d
a
h
C
a
n
a
h
G
i
u
G
n
u
a
s
s
i
B
-
a
e
a
i
b
m
a
G
a
i
p
o
i
h
t
E
a
d
n
a
w
R
a
e
r
t i r
E i
u
G
n a
e
g
n
A
o a
l
r
e
b
i
L
a
i
C
R
D
o
o
g
n n
i
n
e
B
a
r
r
e
i
Se
n
o
e
L
r
u
B
k
o
s
a
F
a
n
i
n
e
S
e
l
a
g
Ma i l r
e
g
i
N
Ma
a
i
n
a
t i r
u
Ma
r
a
c
s
a
g
a
d
s
o
r
o
m
o
C
Table 1 Coverage of HIV programmes and impact of changing
programme coverage and HIV incidence among women on under-5
mortality
Botswana Zimbabwe
Coverage of programmes
PMTCT >90% 56%
Child ART 89% 30%
Cotrimoxazole 60% 30%
Scenarios
Impacts on child mortality due to HIV
Stable incidence 14% 19%
No PMTCT 380% 17%
No ART 5% 5%
No cotrimoxazole 26% 10%
ART, antiretroviral therapy; PMTCT, prevention of mother-to-child transmission of HIV.
Key messages
< In 2009 HIV accounted for 2.1% (1.2e3.0%) of the under-5
deaths in low- and middle-income countries and 3.6%
(2.0e5.0%) in sub-Saharan Africa.
< The percentage of under-5 deaths due to HIV has been falling
in the last decade.
< The fall in under-5 deaths due to HIV has been driven by
a combination of factors, including scale-up of prevention of
mother-to-child transmission and treatment for pregnant
women and children as well as a decrease in HIV prevalence
among pregnant women.
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Supplementbe needed if we are to continue to reduce child deaths due to
HIV.
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